Related Experiment Videos
Convolution-based approaches for in vivo-in vitro correlation modeling
1Office of Clinical Pharmacology and Biopharmaceutics, U.S. Food and Drug Administration, Rockville, Maryland 20857, USA.
Advances in Experimental Medicine and Biology
|January 1, 1997
Summary
This study presents a direct convolution-based approach for in vivo-in vitro correlation (IVIVC) in extended release (ER) oral dosage forms. This method models in vitro release and plasma drug concentrations directly, simplifying analysis and improving prediction of bioequivalence metrics.
Area of Science:
- Pharmacokinetics and Drug Delivery
- Biopharmaceutics
- Mathematical Modeling
Background:
- In vivo-in vitro correlation (IVIVC) is crucial for predicting drug performance.
- Traditional deconvolution methods for IVIVC can be indirect and complex.
- Extended release (ER) oral dosage forms require robust methods for IVIVC.
Purpose of the Study:
- To introduce and detail a direct convolution-based modeling approach for IVIVC.
- To demonstrate the advantages of convolution-based IVIVC over deconvolution methods.
- To explore various convolution-based IVIVC models and their applicability.
Main Methods:
- Directly modeling the relationship between in vitro release and plasma drug concentrations.
- Utilizing convolution integral for drugs with linear, time-invariant disposition.
- Developing extended models for nonlinear absorption or presystemic biotransformation.
Main Results:
- Convolution-based IVIVC directly predicts plasma concentration time courses.
- This approach simplifies interpretation regarding bioequivalence metrics.
- Methods can be constructed without requiring IV, oral solution, or IR reference doses.
Conclusions:
- Convolution-based IVIVC offers a more direct and interpretable alternative to deconvolution.
- The approach is adaptable to various drug properties and study designs.
- This modeling strategy enhances the understanding of in vitro release impact on in vivo drug behavior.